Does Dr. REGINALD BROOKER have financial conflicts of interest?

Dr. REGINALD BROOKER (M.D.) has received a total of $701 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $701 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. REGINALD BROOKER?

According to CMS Open Payments data, Dr. REGINALD BROOKER received funding from ENDO PHARMACEUTICALS ($230), INTEGRA LIFESCIENCES CORPORATION ($149), and ACUMED ($134).

Does Dr. REGINALD BROOKER receive research grants or speaking fees?

Dr. REGINALD BROOKER has received $701 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. REGINALD BROOKER

M.D.Real-Time Hydrated

Specialty: Orthopaedic Surgery, Hand Surgery

Practice Location: CHARLESTON, SC 29414

NPI Number: 1801801253

LIFETIME INDUSTRY VALUE

$701

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. BROOKER is a verified Orthopaedic Surgery, Hand Surgery practitioner based in CHARLESTON, SC.

Between 2021 and 2024, Dr. BROOKER had an overall industry promotional and research financial footprint of $701 as recorded in the federal CMS Open Payments database.

$701 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BROOKER's primary funding source is ENDO PHARMACEUTICALS, which accounts for $230 (representing 32.8% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ENDO PHARMACEUTICALS

Rank 1

$230

32.8%

INTEGRA LIFESCIENCES CORPORATION

Rank 2

$149

21.2%

ACUMED

Rank 3

$134

19.2%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.